152 related articles for article (PubMed ID: 6229898)
1. The behaviour of various platelet function tests during long-term prostacyclin infusion in patients with peripheral vascular disease.
Sinzinger H; Horsch AK; Silberbauer K
Thromb Haemost; 1983 Dec; 50(4):885-7. PubMed ID: 6229898
[TBL] [Abstract][Full Text] [Related]
2. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.
Malpass TW; Amory DW; Harker LA; Ivey TD; Williams DB
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):550-5. PubMed ID: 6231433
[TBL] [Abstract][Full Text] [Related]
3. Platelet proteins during and after prostacyclin therapy for lower limb ischaemia--suggestion of a rebound platelet activation.
Blättler W; Furrer K; Schriber K; Kofmehl R; Massini C
Vasa; 1981; 10(3):261-3. PubMed ID: 6169225
[No Abstract] [Full Text] [Related]
4. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374).
Kappa JR; Cottrell ED; Berkowitz HD; Fisher CA; Sobel M; Ellison N; Addonizio VP
J Vasc Surg; 1987 May; 5(5):693-701. PubMed ID: 2437338
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests.
Gresele P; Catalano M; Giammarresi C; Volpato R; Termini R; Ciabattoni G; Nenci GG; Davì G
Thromb Haemost; 1997 Dec; 78(6):1434-7. PubMed ID: 9423790
[TBL] [Abstract][Full Text] [Related]
6. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
7. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
8. Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD).
Fitscha P; Tiso B; Krais T; Sinzinger H
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():450-4. PubMed ID: 2444079
[No Abstract] [Full Text] [Related]
9. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
10. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
11. [Determination of platelet activation products (platelet factor IV and beta-thromboglobulin) in a group of workers with long-term exposure to carbon disulfide].
Craveri A; Lanfredini M; Tornaghi G; Frangione A; Milella AM; Ranieri R; Tonali M; Gatti L; Franco G; Moia M
G Clin Med; 1980 Nov; 61(11):812-21. PubMed ID: 6165639
[No Abstract] [Full Text] [Related]
12. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
13. Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?
Sinzinger H; Silberbauer K; Horsch AK; Gall A
Prostaglandins; 1981 Jan; 21(1):49-51. PubMed ID: 7010457
[TBL] [Abstract][Full Text] [Related]
14. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
Norris LA; Bonnar J
Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
[TBL] [Abstract][Full Text] [Related]
15. [Amaurosis fungax. Studies on hemodynamics and platelet function].
Bettelheim H; Grabner G; Schuster H; Dudczak R; Lechner K; Niessner H; Valencak E
Klin Monbl Augenheilkd; 1980 Feb; 176(2):328-33. PubMed ID: 6448316
[TBL] [Abstract][Full Text] [Related]
16. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
Berild D; Hasselbalch H; Knudsen JB
Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
[TBL] [Abstract][Full Text] [Related]
17. [Changes in platelet function in patients with arterial hypertension].
Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation markers in long-term follow-up of young subjects with acute myocardial infarction.
Lo Presti R; D'Amico T; Montana M; Canino B; Romano A; Caimi G
Clin Hemorheol Microcirc; 2006; 35(4):527-8. PubMed ID: 17148852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
